Systemic Therapy Updates in Soft Tissue Sarcoma: Does Tazemetostat Improve PFS/OS in Advanced ES? What Is the Response to Larotrectinib in NTRK Gene Fusions Patients? Are Anti-Angiogenic Agents Useful for Desmoid Tumors?